Tissue expression, serum and salivary levels of vascular endothelial growth factor in patients with HNSCC

Brazilian Journal of Otorhinolaryngology

Volumn 80, Issue 6, 2014, Pages 503-507

  Andisheh Tadbir, Azadeh ^a   Hamzavi, Marzieh ^a   Rezvani, Gita ^a   Ashraf, Mohammad Javad ^b   Fattahi, Mohammad Javad ^c   Khademi, Bijan ^c,d   Kamali, Fereshteh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Saliva; Serum; Squamous cell carcinoma; Vascular endothelial growth factors

Indexed keywords

VASCULOTROPIN; TUMOR PROTEIN; VASCULOTROPIN A;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX; LYMPH NODE METASTASIS; MALE; MOUTH CAVITY; PATHOGENESIS; PROTEIN EXPRESSION; RANK SUM TEST; SALIVA LEVEL; STAINING; VOLUNTEER; CANCER STAGING; CASE CONTROL STUDY; CHEMISTRY; CROSS-SECTIONAL STUDY; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; SALIVA; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; SALIVA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84925286958     PISSN: 18088694     EISSN: 18088686     Source Type: Journal    
DOI: 10.1016/j.bjorl.2014.03.001     Document Type: Article

References (23)

1. Sullu Y., Gun S., Atmaca S., Karagoz F., Kandemir B. Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx. Diagn Pathol 2010, 35:35-40.
2. Smith B., Smith G.L., Carter D., Sasaki C.T., Haffty B. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 2000, 18:2046-2052.
3. Khaled M., Le A., Duong H., Wu Y., Zhang Q., Messadi D.V. Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma. Exp Mol Pathol 2004, 76:143-152.
4. Michael J.C., John D., Taro M., Lena C.W. VEGF-receptor signal transduction. Biochem Sci 2003, 28:488-494.
5. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nat Lond J 1993, 362:841-844.
6. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nat Lond J 1992, 359:843-845.
7. Liu C.J., Chang K.W., Lin S.C., Cheng H.W. Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma. Oral Oncol 2009, 45:920-925.
8. Shang Z.J., Li J.R., Li Z.B. Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma. J Oral Maxillofac Surg 2007, 65:17-21.
9. Brooks M.N., Wang J., Li Y., Zhang R., Elashoff D., Wong D.T. Salivary protein factors are elevated in breast cancer patients. Mol Med Rep 2008, 1:375-378.
10. Connolly D.T., Heuvelman D.M., Nelson R. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989, 84:1470-1489.
11. Gazzar R.E., Macluskey M., Williams H., Ogden G.R. Vascularity and expression of vascular endothelial growth factor in oral squamous cell carcinoma, resection margins, and nodal metastases. Br J Oral Maxillofac Surg 2006, 44:193-197.
12. Shang Z.J., Li J.R., Li Z.B. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2002, 31:495-498.
13. Li C., Shintani S., Terakado N., Klosek S.K., Ishikawa T., Nakashiro K. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. Int J Oral Maxillofac Surg 2005, 34:559-565.
14. Tse G.M., Chan W.H., Yu K.H., King A.D., Wong K.T., Chen G.G., et al. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma. Surg Oncol 2007, 14:3558-3565.
15. Kyzas P.A., Stefanou D., Batistatou A., Agnant N.J. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 2005, 131:624-630.
16. Friedrich R.E., Klapdor R., Hagel C., Bartel-Friedrich S. VEGF in sera of oral and oropharyngeal squamous cell carcinoma patients. Anticancer Res 2010, 30:1765-1766.
17. Cheng S.J., Lee J.J., Kok S.H., Chou C.H., Chang H.H., Yang H. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan. J Formos Med Assoc 2011, 110:50-57.
18. Meyer F., Samson E., Pierre D., Duchesne T., Liu G., Bairati I. Serum prognostic markers in head and neck cancer. Clin Cancer Res 2010, 16:1008-1015.
19. Ryuto M., Ono M., Izumi H., Yoshida S., Weich H.A., Kohno K., et al. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. J Biol Chem 1996, 271:28220-28228.
20. Teles R.P., Likhari V., Socransky S.S., Haffajee A.D. Salivary cytokine levels in chronic periodontitis and in periodontally healthy subjects. J Periodontal Res 2009, 44:411-417.
21. Taichman N.S., Cruchley A.T., Fletcher L.M., Hagi-Pavli E.P., Paleolog E.M., Abrams W.R., et al. Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis. Lab Invest J Tech Method Pathol 1998, 78:869-875.
22. Wu X., Zhao H., Do K.A., Johnson M.M., Dong Q., Hong W.K., et al. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res 2004, 10:3988-3995.
23. Upile T., Jerjes W., Kafas P., Harini S., Singh S.U., Guyer M., et al. Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication. Int Arch Med 2009, 2:1-4.